Stocks Health care KOD
NASDAQ · Health careKodiak Sciences Inc. (KOD)
It posted a net loss of $242M. In fiscal 2025 capital spending exceeded operating cash flow by $136.5M. At June 30, 2026 it held $125.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Key facts about Kodiak Sciences Inc.
- Net worth
- Kodiak Sciences Inc. has a market value (market cap) of $6.8B at the latest share price, and shareholders' equity of $61.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used $136M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Kodiak Sciences Inc.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Kodiak Sciences Inc. does
Kodiak Sciences Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker KOD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$230M | -$4.32 | -$136.5M |
| 2024 | n/a | -$176.2M | -$3.35 | -$117.7M |
| 2023 | n/a | -$260.5M | -$4.97 | -$195.5M |
| 2022 | n/a | -$333.8M | -$6.39 | -$243.5M |
| 2021 | n/a | -$267M | -$5.16 | -$199.3M |
| 2020 | n/a | -$133.1M | -$2.91 | -$87.2M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Kodiak Sciences Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 20, 2026
- September 30, 2026Activist stake changed SCHEDULE 13D/A
- September 28, 2026Other event 8-K
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 13, 2026
- August 13, 2026
- June 4, 2026
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 7, 2026
- May 7, 2026
Insider trades
What the people running Kodiak Sciences Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $181.3M and sold $2.7M worth of shares in the last 90 days. All of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 5, 2026 | Baker Bros. Advisors LPDirector, 10% owner | Boughtindirect | 4,703 | $463.3K |
| November 5, 2026 | Baker Bros. Advisors LPDirector, 10% owner | Boughtindirect | 81,729 | $8.1M |
| November 4, 2026 | Baker Bros. Advisors LPDirector, 10% owner | Boughtindirect | 8,742 | $861.2K |
| November 4, 2026 | Baker Bros. Advisors LPDirector, 10% owner | Boughtindirect | 151,916 | $15M |
| October 23, 2026 | Yang TaiyinDirector | Exercised options | 20,000 | $47K |
| October 21, 2026 | Borgeson John A.Chief Financial Officer | Exercised options | 30,000 | $74.7K |
| October 21, 2026 | Borgeson John A.Chief Financial Officer | Soldpre-planned (10b5-1) | 8,514 | $746.4K |
| October 21, 2026 | Borgeson John A.Chief Financial Officer | Soldpre-planned (10b5-1) | 1,677 | $149.6K |
Who owns KOD
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Baker Bros. Advisors LP13D, may seek influence with 3 related filers | 35% | September 30, 2026 |
| D. Victor Perlroth, M.D.13G, passive | 9.9% | February 17, 2026 |
| Sirenia Capital Management LP13G, passive with 1 related filers | 5.7% | May 15, 2026 |
| T. Rowe Price Associates, Inc.13G, passive | 5.2% | August 14, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 200 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Baker Bros. Advisors LP | 19,919,186 | 0 |
| BlackRock, Inc. | 4,135,355 | +200,053 |
| State Street Corp | 2,419,417 | +168,497 |
| Goldman Sachs Group Inc | 2,316,014 | +627,011 |
| Vanguard Capital Management LLC | 1,804,632 | +87,556 |
| Braidwell LP | 1,787,318 | -31,347 |
| Jupiter Topco LLC | 1,526,006 | new |
| Rtw Investments, LP | 1,487,934 | 0 |
| Boxer Capital Management, LLC | 1,477,600 | +116,600 |
| TCG Crossover Management, LLC | 1,445,538 | 0 |
| ICONIQ Capital, LLC | 1,266,563 | 0 |
| Geode Capital Management, LLC | 1,062,955 | +62,544 |
| Ikarian Capital, LLC | 1,059,730 | -206,065 |
| Artisan Partners Limited Partnership | 968,037 | +277,715 |
| Wellington Management Group Llp | 793,613 | +357,284 |
| Board of Trustees of The Leland Stanford Junior University | 691,767 | 0 |
| Silverarc Capital Management, LLC | 546,256 | -445,674 |
| Vanguard Portfolio Management LLC | 532,819 | +167,768 |
| Adage Capital Partners GP, L.L.C. | 500,000 | -75,000 |
| Squadron Capital Management LLC | 500,000 | +120,000 |
Insiders
4 insiders reported holding 24,332,851 shares in total, about $2.63B at the last price.
| Holder | Shares |
|---|---|
| Baker Bros. Advisors LPDirector, 10% owner | 20,424,85920,424,859 held indirectly |
| Perlroth VictorChairman and CEO, Director, 10% owner | 3,676,062 |
| Borgeson John A.Chief Financial Officer | 211,930 |
| Yang TaiyinDirector | 20,000 |
Questions about KOD
What does Kodiak Sciences Inc. do?
Kodiak Sciences Inc. is a company in the Health care sector, listed on NASDAQ as KOD. Its shares trade on NASDAQ under the ticker KOD.
What is Kodiak Sciences Inc.'s net worth?
Kodiak Sciences Inc. has a market value (market cap) of $6.8B at the latest share price, and shareholders' equity of $61.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Kodiak Sciences Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $242M.
When did Kodiak Sciences Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from November 6, 2026.
When is Kodiak Sciences Inc.'s next earnings report?
Kodiak Sciences Inc.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare KOD with
Follow KOD
Get an email when Kodiak Sciences Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Kodiak Sciences Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.